FINANCIAL PERFORMANCE AND GROWTH PROSPECTS OF THE INDIAN PHARMACEUTICAL INDUSTRY: A REVIEW OF PROFITABILITY, INNOVATION, AND EMERGING CHALLENGES

Abstract

The Indian pharmaceutical industry is an important contributor to the
country's economic development and global healthcare supply. India has
established a strong position in the production and supply of generic
medicines, vaccines and pharmaceutical formulations. The industry has
experienced considerable growth due to increasing domestic healthcare
demand, export expansion, manufacturing capabilities and government policy
initiatives. However, the sector also faces challenges associated with global
competition, regulatory compliance, research and development expenditure,
dependence on imported raw materials and pricing pressures. The present
paper reviews the financial performance and growth prospects of the Indian
pharmaceutical industry, with particular emphasis on profitability, innovation,
exports, investment opportunities and emerging challenges. The study is based
on secondary information collected from government reports, industry
publications, official websites and relevant research literature. Available
industry data indicate that the annual turnover of the pharmaceutical sector
increased from ₹3,28,054 crore in FY 2020–21 to ₹4,71,898 crore in FY 2024–
25. The findings highlight the importance of innovation, export
diversification, domestic manufacturing and operational efficiency in
sustaining future growth. The paper concludes that the Indian pharmaceutical
industry has significant opportunities for expansion, provided that companies
strengthen research capabilities, maintain quality standards and improve
financial and technological competitiveness.